Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CUPID: CBN for Insomnia
NCT05344170Phase 2Completed
- Sponsor
- Woolcock Institute of Medical Research
- Start
- Aug 2022
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabinol in chronic insomnia disorder (CID), sponsored by Woolcock Institute of Medical Research. Started Aug 2022; status: completed.
02
Drugs
cannabinol
03
Conditions
chronic insomnia disorder (CID)
Beyond the preview
Go deeper on NCT05344170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05344170.